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UncouplingMitochondria-targeted polyphenols are being developed with the intent to intervene on the levels of
reactive oxygen species (ROS) in mitochondria. Polyphenols being more than just anti-oxidants, the
interaction of these derivatives with the organelles needs to be characterised. We have studied the effects
of two quercetin derivatives, 3-(4-O-triphenylphosphoniumbutyl)quercetin iodide (Q3BTPI) and its
tetracetylated analogue (QTA3BTPI), on the inner membrane aspeciﬁc permeability, transmembrane
voltage difference and respiration of isolated rat liver mitochondria. While the effects of low
concentrations were too small to be reliably deﬁned, when used in the 5–20 μM range these compounds
acted as inducers of the mitochondrial permeability transition (MPT), an effect due to pro-oxidant activity.
Furthermore, Q3BTPI behaved as an uncoupler of isolated mitochondria, causing depolarisation and
stimulating oxygen consumption. When applied to tetramethylrhodamine methyl ester (TMRM)-loaded
HepG2 or Jurkat cells uptake of the compounds was predictably associated with a loss of TMRM
ﬂuorescence, but there was no indication of MPT induction. A production of superoxide could be detected
in some cells upon prolonged incubation of MitoSOX®-loaded cells with QTA3BTPI. The overall effects of
these model mitochondriotropic polyphenols may thus differ considerably depending on whether their
hydroxyls are protected or not and on the experimental system. In vivo assays will be needed for a
deﬁnitive assessment of their bioactivities.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The production of Reactive Oxygen Species (ROS) in cells, and in
particular by mitochondria, is considered to be a major factor in
aging and degenerative processes (e.g.: [1–5]) with the implication
that undesirable organism deterioration may be slowed down by
anti-oxidants. Anti-oxidants, including polyphenols, are thus, Bathofenanthrolinedisulfonic
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ll rights reserved.included in some cosmetics and nutritional supplements. In
ischemia/reperfusion (I/R) injury, much of the damage is sustained
when circulation is reinstated. A major role in cell death under
these circumstances is played by the Mitochondrial Permeability
Transition (MPT), a process induced by matrix Ca2+ overload and
oxidative conditions [6–8]. The involvement of ROS in MPT
induction is clearly recognised (e.g.: [2,9,10], and antioxidants
may be expected to exert a protective effect. This has led to an
ongoing effort to develop “mitochondriotropic” antioxidants [11–
18], including polyphenols [19,20], mainly with the goal of
counteracting these undesirable redox-mediated effects. However,
μM concentrations of mitochondria-targeted quercetin and resver-
atrol derivatives proved to be cytotoxic for rapidly dividing cultured
cells [19,20], suggesting a potential as chemotherapeutic agents.
Understanding the reasons for this cytotoxicity ought to help the
design of other mitochondria-targeted antioxidants and the utilisa-
tion of already available ones.
It is therefore important to characterise the effects of these
mitochondria-targeted compounds on isolated mitochondria and on
the organelles in cells to gain a sense of what may happen in vivo.
Here we report our observations with isolated rat liver mitochondria
(RLM), cultured HepG2 and Jurkat cells, and two mitochondria-
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quercetin iodide (Q3BTPI) and 3′,4′,5,7-tetra-O-acetyl-3-(4-O-triphe-
nylphosphoniumbutyl)quercetin iodide (QTA3BTPI).
2. Materials and methods
2.1. Cells and mitochondria
HepG2 cells were grown in Dulbecco's Modiﬁed Eagle Medium
(DMEM) (GIBCO) plus 10 mM HEPES buffer, 10% (v/v) fetal calf
serum (Invitrogen), 100 U/mL penicillin G (Sigma), 0.1 mg/mL
streptomycin (Sigma), 2 mM glutamine (GIBCO) and 1% nones-
sential amino acids (100×solution; GIBCO), in a humidiﬁed atmo-
sphere of 5% CO2 at 37 °C. Jurkat cells were grown in RPMI-1640
medium supplemented as above plus 50 μM β-mercaptoethanol. Rat
liver mitochondria (RLM) were prepared by standard differential
centrifugation procedures and obtained as a suspension in 0.25 M
sucrose, 5 mM Hepes/K+, pH 7.4.
2.2. TPP-sensitive electrode
The setup used to monitor the concentration of triphenylpho-
sphonium-bearing compounds in solution was built in-house
following published procedures [21,22]. In these electrodes the
diffusion of the charged, permeant compound across a permeable
polyvinylchloride (PVC) ﬁlm gives rise to a half-cell potential
logarithmically related to the concentration of the compound
according to Nernst's law. The ﬁlm is permeable because doped
with tetraphenylborate anion, which acts as a carrier. Such an
electrode will respond to all cations capable of diffusing into the PVC
ﬁlm as an ionic couple with tetraphenylborate, i.e., in practice, to
triphenylphosphonium-comprising organic molecules. A calomel
electrode was used as reference and the potentiometric output was
directed to a strip chart recorder. The experiment illustrated in Fig. 1
was conducted at 20 °C.Fig. 1. (A) Accumulation of Q3BTPI by RLM. The response of a TPP-sensitive electrode is
shown. Arrows indicate the addition of 0.4 μMQ3BTPI to standard medium. Addition of
RLM (1 mg prot.mL−1) causes an upward deﬂection of the trace since respiring
mitochondria take up the positively charged compound, which also bind in part to
mitochondrial components. Addition of FCCP causes release. (B) Chemical structures of
Q3BTPI and QTA3BTPI.2.3. Swelling and respiration assays
Preparation of RLM and swelling and respiration assays were
carried out as described in [23]. The standard medium contained
250 mM sucrose, 10 mM Hepes/K+, 5 mM succinate/K+, 1.25 μM
rotenone, 1 mM Pi/K+, pH 7.4, supplemented with the desired
concentration of CaCl2. RLM were used at a concentration of 1 or
0.5 mg.prot.mL−1. Direct determinations of the effects of Q3BTPI
on respiration using a Clark electrode could not be carried out
because Q3BTPI diffused through the semi-permeable Teﬂon
membrane covering the working surface of the electrode (a
cathode at which approximately −0.7 V are applied), and reacted
there forming black polymeric products which rapidly gummed up
the surface making the electrode unserviceable.
2.4. Fluorimetric assays of mitochondrial potential
Rhodamine 123 (75 nM) ﬂuorescence was used to monitor the
transmembrane potential of isolated RLM suspended (0.5 mg.prot.
mL−1) in standard medium in a stirred quartz cuvette placed in a
Shimadzu RL-5000 spectroﬂuorimeter at R.T. Excitation was at
503 nm (3 nm slit), and ﬂuorescence was collected at 523 nm
(5 nm slit).
Tetramethylrhodaminemethyl ester (TMRM; Invitrogen/Molecular
Probes) staining of cells was used tomonitor mitochondrial transmem-
brane potential in cultured cells. HepG2 cells were seeded onto 24-mm
coverslips in 6-well plates and grown for about two days, avoiding
conﬂuence. Coverslips were mounted onto holders, exposed to 20 nM
TMRM in DMEMor HBSS (inmMunits: NaCl 136.9, KCl 5.36, CaCl2 1.26,
MgSO4 0.81, KH2PO4 0.44, Na2HPO4 0.34, glucose 5.55, pH 7.4 with
NaOH) for about 20min, generally in thepresence of 4 μMCyclosporinH
or 2 μM Cyclosporin A depending on the details of the experimental
protocol, and washed twice. Cells were then covered with 1 mL of the
desired medium and observed at room temperature. Images were
acquired automatically at 1- or 2-min intervals, using an Olympus
Biosystems apparatus comprising an Olympus IX71 microscope and
MT20 light source, and processed with CellR© software. Excitation was
at 568±25nmandﬂuorescencewas collectedusing a 585-nm longpass
ﬁlter. Additions were performed by withdrawing 0.5 mL of incubation
medium, adding the desired solute to this aliquot, mixing, and adding
back the solution into the chamber at a peripheral point.
A Beckton Dickinson Canto II ﬂow cytometer was used to monitor
TMRM ﬂuorescence of Jurkat cells. The cells were washed in HBSS,
suspended in FACS buffer (135 mM NaCl, 10 mM Hepes, 5 mM CaCl2,
pH 7.4) at a density of 1.5×106/mL and loaded with 20 nM TMRM
(37° C, 20 min). Cells were then diluted 1:5 in FACS buffer and divided
into the desired number of identical aliquots. At time zero the desired
compound was added, and data collected after the desired incubation
times, exciting at 545 nm andmeasuring ﬂuorescence at 585 nm. Data
were analysed using the BD VISTA software. Experiments could be
performed only with QTA3BTPI because Q3BTPI signiﬁcantly altered
the scatter parameters of a large fraction of the cells.
2.5. Superoxide production assays
Dihydroethidine (Invitrogen/Molecular Probes) assays were used
as described in [23] to detect the production of O2·- in RLM
suspensions. Superoxide generation in cells was followed using the
mitochondriotropic probe MitoSOX Red® (Invitrogen/Molecular
Probes) used as speciﬁed by the producer. Cells were incubated for
15 min with 1 or 2 μMMitoSOX Red® in HBSS, washed twice, covered
with 1mLHBSS, and placed on themicroscope stage. Excitationwas at
500–520 nm, and ﬂuorescence was collected at λN570 nm. Images
were automatically acquired at 1 or 2 min intervals as above. These
experiments could be conducted only with QTA3BTPI and 5 μM
Q3BTPI, because 20 μMQ3BTPI apparently interacted withmitoSOX to
Fig. 2. Effects of Q3BTPI and QTA3BTPI on isolated rat liver mitochondria in the absence
of added Ca2+. Parallel light scattering experiments initiated by the addition of 1 mg.
prot.mL−1 RLM to the cuvettes. Pseudo-absorbance was monitored at 540 nm. The
medium contained: (A) traces 1–5 and trace 9: Q3BTPI 20 μM; traces 2,5: CsA 1 μM;
trace 3: FCCP 1 μM; trace 6: Ph4P+Cl- 20 μM; trace 8: CaCl2 80 μM; trace 9: EGTA 100 μM;
traces 4, 5, 7, 8: the incubation medium saturated with oxygen; (B) traces 1–3:
QTA3BTPI 20 μM; trace 2: CsA 1 μM; trace 3: EGTA 100 μM; traces 4–6: Q 20 μM; trace 5:
CsA 1 μM; trace 6: EGTA 100 μM.
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storm” effect which masked any ﬂuorescence increase.
FACS experiments with Jurkat cells were conducted as described
for TMRM ﬂuorescence determinations, loading with 1 μM MitoSOX
Red®. Also in this case analyses could be performed only with
QTA3BTPI.
2.6. QTA3BTPI stability in mitochondrial suspensions
QTA3BTPI was added to a 1 mg.prot.mL−1 suspension of RLM in
standard medium to give a 20 μM solution. 100 μL samples were
withdrawn, stabilised with 1 mM ascorbate and 0.06 M acetic acid,
and mixed with an equal volume of acetone. After sonication the
solids were separated by centrifugation. The supernatant was
concentrated under N2 and analysed. LC-ESI/MS analyses and mass
spectra were performed with a 1100 Series Agilent Technologies
system, equipped with binary pump (G1312A) and MSD SL Trap
mass spectrometer (G2445D SL) with ESI source. Samples (20 μl)
were injected onto a reversed phase column (Gemini C18, 3 μm,
150×4.6 mm i.d.; Phenomenex). Solvents A and B were H2O
containing 0.1% formic acid and CH3CN, respectively. The gradient
for B was as follows: 30% for 5 min, from 30% to 60% in 15 min, from
60% to 100% in 3 min; the ﬂow rate was 0.7 mL/min. The eluate was
monitored at 300 nm.
3. Results
To assess the effects of Q3BTPI and QTA3BTPI on isolated rat liver
mitochondria we monitored three classical readouts of bioenergetics
experiments: mitochondrial volume (as reﬂected by light scattering),
transmembrane potential and oxygen consumption. These para-
meters, and their variation in response to pharmacological agents,
vary to some extent from one preparation to the other. The direct
comparisons presented in this paper are based on data obtained with
the same preparation.
As an initial step we simply mixed the compounds with RLM
suspended in an isotonic sucrose-based medium. Both QTA3BTPI [19]
and Q3BTPI (Fig. 1) can be observed to accumulate into isolated
mitochondria by monitoring their concentration with a TPP-respon-
sive electrode. Note that Q3BTPI is only partially released upon
uncoupling of the organelles indicating that much of the compound is
actually bound. Polyphenols arewell known to bind avidly to proteins,
and the TPP moiety is also understood to participate in interactions
with membranes and with macromolecules bearing negative charges
(DNA). The group of Smith and Murphy has recently produced a
quantitative study of the partition of mitoQ in cells: most of the
compoundwas found to bind to cellular components [24]. Acetylation
of the OH groups allows faster redistribution and less extensive
binding of QTA3BTPI [19].
Fig. 2A illustrates the results of light-scattering experiments with
Q3BTPI under these conditions (N=3). In this as well as in the other
ﬁgures representative experiments are shown, utilising concentra-
tions of the compounds producing a marked change of the readout
parameter. Lower concentrations always had similar, but less evident,
effects or produced variations too small for a reliable assessment. In
the presence of 20 μM Q3BTPI (trace 1) swelling ensued which was
not observed when no addition was made (trace 7, with oxygenation)
or in the presence of 20 μM tetraphenylphosphonium chloride (trace
6). The latter induced only a much slower and lower-amplitude
swelling, presumably due to the energy-driven uptake of the
osmotically active solute since it was abolished by FCCP (not
shown). The pseudo-absorbance decrease induced by Q3BTPI was in
turn more modest than that associated with full-blown Ca2+-induced
permeability transition (trace 8), it was partly sensitive to Cyclosporin
A (trace 2) and EGTA (trace 9), abolished by FCCP (trace 3) and it was
interrupted by a sudden inversion (traces 1, 2). The latter wasassociated with the near-exhaustion of the oxygen supply in the
spectrophotometer cuvette, since saturating the suspension medium
with oxygen beforehand delayed the phenomenon (traces 4, 5). This
behaviour indicates that oxygen consumption was strongly enhanced
by Q3BTPI. This could not be conﬁrmed directly by measurements
with a Clark electrode, because Q3BTPI reacted at the electrode
surface producing a tarry substance which rapidly rendered the
electrode useless. Oxygenation on the other hand increased the CsA-
sensitive portion of the pseudo-absorbance decrease (compare traces
1, 2 vs. 4, 5), i.e., the rate of propagation of the permeability transition
in the suspension, conﬁrming that this phenomenon is mediated by
oxidative events [23].
The acetylated derivative–QTA3BTPI–and quercetin affected
swelling differently, as illustrated in Fig. 2B. In the absence of
added Ca2+ quercetin in the 10–50 μM range had little effect (cf.
trace 4 in Fig. 2B). QTA3BTPI on the other hand induced large
amplitude swelling (trace 1) which was essentially abolished by both
cyclosporin A and EGTA (traces 2 and 3), and can thus be attributed
to the permeability transition taking place in the presence of
“contaminating” Ca2+.
These results suggested that both Q3BTPI and QTA3BTPI acted as
inducers of the MPT in synergy with any Ca2+ present. In this capacity
QTA3BTPI seemed to be more efﬁcient than Q3BTPI (in Fig. 2 compare
trace 1 minus trace 2 in panel B for QTA3BTPI vs. trace 1 minus trace 2
in panel A for Q3BTPI), which in turn was more efﬁcient than
quercetin itself (trace 4 minus trace 5 in panel B). These indications
were conﬁrmed by experiments performed in the presence of near-
threshold [Ca2+], i.e. of a concentration of Ca2+ sufﬁcient for only a
slowly-developing MPT-associated swelling in the absence of another
Fig. 4. Deacetylation of QTA3BTPI in the presence of RLM. HPLC chromatograms
(300 nm) recorded after different incubation periods of QTA3BTPI with a RLM
suspension (1 mg.prot.mL−1). Peak identity was determined by ESI/MS analysis.
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always profoundly inhibited by CsA, at variance from that caused by
Q3BTPI, which was only partially sensitive (in Fig. 3 compare trace 2
for QTA3BTPI+CsA with trace 4 for Q3BTPI+CsA). Thus, while
QTA3BTPI is more efﬁcient at inducing the MPT, Q3BTPI is more
efﬁcient at inducing CsA-insensitive swelling. These properties clearly
must be related to the presence of free OH groups in Q3BTPI.
Quercetin has been shown to induce the MPT via a metal ion-
catalyzed oxidative process [23] and the same mechanism may be
envisioned for the present compounds. In the presence of metal ions
with multiple possible oxidation states (mainly Fe2+/3+ and Cu+/2+)
polyphenols, especially if comprising a catechol moiety, may oxidize
in chain reactions producing superoxide and hence H2O2. The latter
can then undergo Fenton-type reactions producing more aggressive
hydroxy and peroxy radicals [25,26]. Oxygen radicals, or, in general,
oxidising conditions, are well known to favour the onset of theMPT by
acting on key thiol residues [27–29].
MPT induction by QTA3BTPI was somewhat unexpected because
the hydroxyls, the sites of oxidation in quercetin, are protected by
acetylation. LC/MS analysis revealed that QTA3BTPI undergoes partial
deacetylation, producing oxidisable species still capable of electro-
phoretic accumulation into energised mitochondria (Fig. 4). However
over the time course of a swelling experiment essentially no Q3BTPI is
produced: the main species found at 15min still retain two or three of
the original four acetyl groups.
The intervention of radicalic/oxidative processes in the onset of
QTA3BTPI-induced MPT and, in part, of Q3BTPI-induced swelling was
conﬁrmed by the inhibition afforded by BHT+DTT (Fig. 5A) (N=3).
In the case of quercetin, MPT induction was antagonised by Fe and Cu
chelating agents [23], indicating the involvement of Fenton reactions
catalysed by metallic species released by or associated with the
mitochondria themselves. Selective chelators also affected Q3BTPI
and Ca2+-associated swelling (Fig. 5B) (N=3), reducing not only the
CsA-sensitive component of the swelling curve, but also the CsA-
insensitive one (compare traces 6 and 7 in Fig. 5B). This suggests that
CsA-insensitive swelling is also largely mediated by ROS produced by
metal-catalysed processes, presumably via aspeciﬁc membrane
permeabilisation by lipoxidation. On the other hand in the case of
QTA3BTPI this protective effect was practically absent (compare
traces 1 and 2). This would be expected if in this case the relevant
redox events took place mostly in the mitochondrial matrix, where
QTA3BTPI accumulates. The matrix is inaccessible to BC and BF which
are sulfonated (i.e., negatively charged) molecules.
QTA3BTPI is much less reactive than Q3BTPI at the Clark electrode
surface, and its effects on respiration can therefore be assessed byFig. 3. Effects of Q, Q3BTPI and QTA3BTPI on isolated rat liver mitochondria in the
presence of exogenous Ca2+. Light scattering experiments analogous to those of Fig. 2.
In all cases the medium was saturated with oxygen and contained CaCl2 50 μM plus:
traces 1,2: QTA3BTPI 10 μM; trace 2: CsA 1 μM; traces 3,4: Q3BTPI 20 μM; trace 4: CsA
1 μM; traces 5, 6: Q 40 μM; trace 6: CsA 1 μM.polarography. As expected, in the presence of Ca2+ its addition caused
an acceleration of the rate of oxygen consumption which was blocked
by CsA (not shown). An increase in respiratory rate normally implies
“uncoupling” of the mitochondrial energy conversion process, which
in turn, according to the chemiosmotic model, implies a decrease of
the transmembrane electrochemical proton gradient (Δµ̃H). To verify
whether such a decrease was taking place we used the ﬂuorescent
transmembrane potential (ΔΨ) indicator dye Rhodamine 123
(Rh123). In these experiments Rh123 was added to the suspension
and equilibrated, so that some was always present outside mitochon-
dria. The high (0.5mg.prot./mL) density of the latter then insured that
any dye released upon depolarisation could be rapidly taken up again
upon repolarisation. Q3BTPI indeed induced a sustained recovery of
Rh123 ﬂuorescence, corresponding to a decrease of ΔΨ, when added
to a suspension of RLM, also if no Ca2+was added and CsAwas present
to block the MPT (Fig. 6A) (N=3). QTA3BTPI had an analogous
depolarising effect (Fig. 6B). In the presence of CsA, however, the
increase of Rh123 ﬂuorescence was transient, suggesting a rapid
depolarisation due to inﬂux of the permeant cation followed by a
slower repolarisation taking place on the time scale of a few minutes
(Fig. 6C; N=4), as the compound was taken up and an equilibrium
distribution was approached. Quercetin itself had little effect under
the same conditions (not shown).
We then checked whether our compounds affected mitochondria
inside cultured cells (Fig. 7). We followed the mitochondrial potential
via TMRM ﬂuorescence. In the experiments of Fig. 7A, representative
of 37 separate ones under various conditions, HepG2 cells were
loaded with TMRM in the presence of CsH (to inhibit MDR pumps;
CsH, contrary to CsA, does not prevent theMPT) and then incubated in
HBSS without any pharmacological agent. Under these conditions
there was a background loss of TMRM ﬂuorescence (plot “a”), which
was hardly affected by the addition of 5 μM Q3BTPI (plot “b”), while
Fig. 5. Contribution of Fe and Cu ions and radical species to the induction of the
mitochondrial permeability transition by Q3BTPI and QTA3BTPI. Light scattering
experiments analogous to those in Figs 2 and 3. In all cases the medium was saturated
with oxygen. (A) All traces: CaCl2 50 μM. Traces 1, 2: QTA3BTPI 10 μM; trace 2: BHT and
DTT, 1 mM each; traces 3, 4: Q3BTPI 20 μM; trace 4: BHT and DTT, 1 mM each. (B) The
medium contained CaCl2 40 μM plus: traces 1–3: QTA3BTPI 10 μM; trace 2: BF and BC,
10 μM each; trace 3: CsA 1 μM; traces 4–7: Q3BTPI 20 μM; trace 5: BF and BC, 10 μM
each; trace 6: CsA 1 μM; trace 7: BF and BC, 10 μM each, and CsA 1 μM.
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may be explainable in terms of the sequestration of a fraction of this
compound by cellular structures.
QTA3BTPI is expected to bind less avidly, since its hydroxyls are
capped, and it has been directly observed to accumulate into in situ
mitochondria [19]. Accordingly, its addition induced a more pro-
nounced but transient acceleration of the ﬂuorescence decrease (plot
“d”), which was not affected by either CsA or BHT+DTT (1 mM each)
(not shown), ruling out the MPT as its origin. Fluorescence loss
proceededwith kinetics comparable to those of QTA3BTPI uptake [19],
suggesting that the two phenomena are correlated, i.e., the process
may be ascribable to the depolarisation associated with uptake of a
permeant cation. A protonophoric cycle by (partially) deacylatedFig. 6. Effects of Q3BTPI and QTA3BTPI on mitochondrial membrane potential. Variations of
10 μM addition); (B, C) QTA3BTPI (each arrow represents a 20 μM addition). In A and C, Csspecies may also intervene. The same type of behaviour by QTA3BTPI
was observedwhen Jurkat cellswere analysed by cytoﬂuorimetry (Fig.
7B, C). In the case of Q3BTPI reliable data could not be obtained (see
Materials and methods). In experiments with cells loss of TMRM
ﬂuorescence does not necessarily indicate an irreversible, permanent
depolarisation of the mitochondria. Cells are pre-loaded with TMRM
and then washed, so that no dye is present outside cells, a non-
equilibrium situation. Indeed, TMRM slowly leaks out of cells under
our control conditions. The cells face an extremely larger volume of
incubation medium. Under these conditions, any TMRM lost because
of a transient depolarisation would not be expected to be regained
upon a subsequent recovery of the mitochondrial potential. Thus,
ﬂuorescence loss indicates depolarisation, but does not necessarily
indicate by itself a permanent depolarisation or damage.
Quercetin induces the production of superoxide anion by isolated
mitochondria as well as by cultured cells [23]. We could not obtain
clear evidence of an analogous effect by Q3BTPI or QTA3BTPI on
isolated mitochondria using HE or mitoSOX®. A reliable assessment of
the effect of Q3BTPI on the response of MitoSOX® in HepG2 or Jurkat
cells was made difﬁcult by technical problems at 20 μM (see Materials
and methods) and was not robust enough to reach deﬁnite
conclusions at the 5 μM level. Addition of QTA3BTPI resulted instead
in a ﬂuorescence increase, which took place also in the presence of
CsA (Fig. 8). In microscopy experiments an heterogeneity of cell
behaviour was evident, as illustrated by the different increases of the
ﬂuorescence associated with two cells in the same ﬁeld shown in
Fig. 8A (plots “b” and “c”).
4. Discussion
The results presented above plausibly identify the mechanisms
responsible for the cytotoxicity of Q3BTPI and QTA3BTPI. They have
been obtained in vitro, with relatively high concentrations, but we
believe they are relevant also for an eventual in vivo utilisation of the
compounds, since much the same mechanisms and requirements
would be expected to apply. Polyphenols per se have rather poor
bioavailability, and when administered in foods or beverages they are
unlikely to reach μM-range concentrations in blood and organs
(except as phase II conjugates). Here we are however considering
not the natural compounds, but their derivatives, which may be
considered as drugs, and administered in various ways. Pharmaco-
logical delivery methods can be expected to result in much higher
levels, at least locally.
We rationalise the behaviour of Q3BTPI vs. isolated mitochondria
in terms of three major concomitant processes: uncoupling of the
mitochondria by Q3BTPI acting as a protonophore (Fig. 9), MPT
induction–involving Ca2+ and ROS in analogy to the process induced
by quercetin itself under similar conditions [23]–and CsA-insensitive
permeabilisation of the IMM, with consequent swelling, due to the
action of ROS on membrane lipids. The uncoupling effect of Q3BTPIRhodamine 123 ﬂuorescence upon additions of: (A) Q3BTPI (each arrow represents a
A 1 μM was present during the experiment.
Fig. 8. Superoxide production in cells exposed to QTA3BTPI, monitored using MitoSOX
Red®. (A) Representative ﬂuorescence microscopy experiments with MitoSOX Red®-
loaded HepG2 cells. A computer-generated plot of the ﬂuorescence emitted by ﬁeld
areas (Regions Of Interest, ROI) coinciding with a cell (a–c) or a portion of background
(d). Images were acquired every 2 min. Plot “a” presents the ﬂuorescence associated
with a cell in a separate control experiment without additions. 20 μM QTA3BTPI was
added, when indicated, in plots “b” and “c”, which report the ﬂuorescence associated
with two cells in the same ﬁeld (plot “d” also comes from the same experiment). See
Materials and methods for details. (B) Representative FACS experiments with 0 (red;
control), 5 (green) or 20 μM (black) QTA3BTPI additions. The graph plotted in blue refer
to a parallel experiment with 20 μM QTA3BTPI in the presence of 5 μM CsA. Plotted are
the normalised median values of histograms such as those shown in panel C. The
median of the histogram recorded immediately after the addition of QTA3BTPI was set
as 100%. (C) The set of histograms obtained in the experiment with 20 μM QTA3BTPI in
the presence of CsA shown in panel B (blue plot) is shown as an example.
Fig. 7. Mitochondrial membrane potential in cells exposed to Q3BTPI and QTA3BTPI,
monitored using TMRM. (A) Representative ﬂuorescence microscopy experiments with
TMRM-loaded HepG2 cells. Computer-generated plots of the ﬂuorescence emitted by
the ﬁeld areas (Regions Of Interest, ROI) coinciding with one cell or a portion of
background (f). Images were acquired every 60 s. Plot “a” represents a control
experiment without addition. Plot “b”: Q3BTPI 5 μM; plot “c”: Q3BTPI 20 μM; plot “d”:
QTA3BTPI 5 μM; plot “e”: QTA3BTPI 20 μM. Compound additions are indicated by
arrows. Plots have been shifted along the ordinate axis for clarity. See Materials and
methods for details. (B) Representative FACS experiments with 0 (red; control), 5
(green) or 20 μM (black) QTA3BTPI additions. The experiment was conducted in the
presence of 5 μM CsA. Plotted are the normalised median values of histograms such as
those shown in panel C. The median of the histogram recorded immediately after the
addition of QTA3BTPI was set as 100%. (C) The set of histograms obtained in the
experiment with 5 μM QTA3BTPI shown in panel B is shown as an example.
194 L. Biasutto et al. / Biochimica et Biophysica Acta 1797 (2010) 189–196can be explained as follows: Q3BTPI exists in solution as a mixture of
instantaneously fully protonated (i.e., positively charged due to the
TPP group) and deprotonated species (the ﬁrst pKa of quercetin is
close to 7 [30–32]). The mitochondrial ΔΨ will drive the uptake of
fully protonatedmolecules, the chemical gradient between the matrix
and the suspension mediumwill drive the efﬂux of the unprotonated,
zwitterionic specie. A ΔΨ-decreasing, respiration-stimulating proto-
nophoric futile cycle will thus be generated. Flavonoids have already
been identiﬁed as potential uncouplers [33], but the presence of themembrane-permeating positive charge enhances this characteristic:
quercetin itself is not active as an uncoupler at concentrations below
1 mM [33], while Q3BTPI uncouples in the μM range. Active uptake of
Q3BTPI by energised mitochondria is therefore self-limiting.
Direct comparison shows that both QTA3BTPI and Q3BTPI are
more efﬁcient MPT co-inducers than quercetin (Fig. 3) in RLM. Since
these compounds are accumulated inside suspended mitochondria,
this indicates that induction can be mediated by phenomena taking
place in the matrix. The higher efﬁciency is then presumably
accounted for by the higher concentration of inducer on the matrix
side of the inner mitochondrial membrane (IMM) (in comparison
with an analogous experiment with quercetin). While the two
mitochondriotropic compounds are better inducers than quercetin,
Fig. 9. An illustration of how Q3BTPI may act as a protonophore and uncoupler. See text for details.
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case of Q3BTPI this may be explained by uncoupling, which limits
matrix accumulation of both Ca2+ and inducer. QTA3BTPI is expected
to be less effective than quercetin or Q3BTPI, at parity of concentra-
tion, because its hydroxyls are at least initially blocked (see Fig. 4).
The observations on cultured cells differ in some respects from
thosewith isolatedmitochondria, indicating that theMPT is much less
readily induced in in situ mitochondria. This is coherent with the low
concentration of Ca2+ and of transition metals–the two factors
involved in MPT induction with isolated RLM–in the cytoplasm. At
least in the case of QTA3BTPI, MPT-independent (because CsA-
insensitive) production of superoxide and some loss of ΔΨ takes
place. Other mitochondriotropic polyphenols may well behave
differently, depending on their physico-chemical properties, but
compounds of this class are in any case to be studied with care: it is
not clear that in vivo theywould behave only as beneﬁcial antioxidants
and ROS quenchers. The results of this investigationmay be taken into
consideration for the design of other mitochondriotropic compounds:
features conferring protonophoric/uncoupling properties will best be
avoided if the intention is to produce a cell-saving anti-oxidant
molecule, and may conversely be desirable if a candidate for
chemotherapeutic applications is desired. Usefulness in oncology
may also bemaximised by taking into account the ﬁndings that cancer
cells have elevated levels of copper ions [34] and of oxidative stress
[35]. On the other hand mild uncoupling of mitochondria is proposed
to have potentially beneﬁcial effects, such asmimicking life-extending
caloric restriction (e.g.: [36,37]) and protecting neurons against
excitotoxicity (e.g.: [38]). Thus, a less readily oxidisable polyphenol
derivative with mild uncoupling activity may also ﬁnd applications.
Literature reports suggest that concentration, or dosage, may well
be an important parameter determining the overall effect of a
(mitochondriotropic) polyphenol. For example, EpiGalloCatechin-
Gallate (EGCG) may have anti-oxidant and “cell-protective” effects
at low dosages (bμM), and pro-oxidant, cytotoxic effects at higher
levels [39]. MitoQ, the best studied mitochondriotropic antioxidant,
changes from an anti-oxidant to a pro-oxidant behaviour over a
relatively small concentration range ([5] and references therein). Low
doses of mitochondria-targeted plastoquinone derivatives reportedly
exert very beneﬁcial effects in vivo [5]. It remains to be seen whether
the present compounds may display divergent effects at very low
concentration, and whether there may be relatively sharp thresholds
for these hypothetical different activities. It also remains to be seen
what concentrations may be attained in the organs of laboratory
animals, and by what means. Furthermore, as mentioned, the bio-
activity of polyphenols is not limited to redox effects. The investigationof the activity of mitochondriotropic polyphenols in vivo will need
therefore to consider several “readout” parameters, the most impor-
tant obviously being the impact on physiological or pathological
conditions of interest.
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